線維筋痛症治療の世界市場規模・シェア・産業動向分析レポート：薬剤クラス別、流通チャネル別、地域別の展望・予測、2023年～2030年

線維筋痛症治療の市場規模は2030年までに40億米ドルに達し、予測期間中にCAGR 4.4%の市場成長率で上昇すると予測されます。

慢性線維筋痛症は、患者の典型的な社会活動や職業活動を大幅に制限し、友人、家族、同僚との関係維持を困難にします。あらゆる種類の痛み、疲労、睡眠障害、うつ病の症状には、利用可能な薬では完全に対処することはできません。線維筋痛症に対するより優れた、より効果的な治療法に対するニーズの高まりにより、製薬会社は研究開発の取り組みを継続し、市場を牽引することになります。ループスは一般的な（慢性の）自己免疫疾患であり、衰弱させ、様々な身体システムに影響を及ぼす可能性があります。ループスは、通常、感染や病気から身体を防御するのに役立つ免疫系が、その組織を標的にすることで発症します。その結果、ループスの症例数とともにその有病率も上昇し、線維筋痛症の治療オプションに対する需要を煽り、市場拡大の原動力となることが予想されます。

しかし、線維筋痛症は、副作用がない一方で多くの利点を持つ非薬物代替療法で管理することができます。そのひとつがストレス管理です。これは、過労や感情的緊張を防いだり軽減したりする戦略を立て、毎日のリラックスタイムを確保することで効果を発揮します。これは、予測される期間における市場成長の妨げになると予想されます。米国国立生物工学情報センター（NCBI）の研究によると、線維筋痛症はCOVID-19から回復した人たちの間で広まっていると報告されています。このデータは、線維筋痛症がCOVID-19に罹患した人に多く、パンデミック後の治療の必要性を高めている可能性を示唆しています。したがって、パンデミックにより市場は減少したが、その後、FM症例の増加により市場は回復し始めました。

薬剤クラスの展望

薬剤クラスによって、市場は抗うつ薬、抗けいれん薬、筋弛緩薬、その他に区分されます。抗うつ薬セグメントは、2022年の市場でかなりの収益シェアを獲得しました。これは、線維筋痛症患者にとって利用しやすい抗うつ薬の選択肢が複数あるためです。複数の抗うつ薬が容易に入手可能であるため、処方の柔軟性が高まり、各患者が適切な治療を受けられる可能性が高まります。この市場の拡大は、線維筋痛症患者への使用が承認された抗うつ薬のジェネリック医薬品が入手可能になったことも後押ししていると予想されます。

流通チャネルの展望

流通チャネル別に見ると、市場は病院薬局、ドラッグストア・小売薬局、オンラインプロバイダーに分けられます。2022年の市場規模は、ドラッグストア・小売薬局が最も大きいです。このセグメントの成長は、ドラッグストア・小売薬局が多様な地域やコミュニティの複数の場所に存在し、一般市民が広くアクセスできることによります。このように至る所に存在することで、線維筋痛症の患者にとって薬剤や治療法への容易なアクセスが保証されます。

地域の展望

地域別に見ると、市場は北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されます。北米地域は、2022年の市場において最も高い収益シェアを記録しました。これは、線維筋痛症の有病率の増加、新しい治療法の選択肢、医療インフラのサポートなど、いくつかの変数によるものです。重要な医療インフラ、高い購買力、線維筋痛症治療薬の受け入れ拡大が市場拡大に拍車をかけると予想されます。また、この地域の市場は、多数の有力企業や、これらの企業が効果的な製品を製造するために使用する製造技術の新興国市場開拓によっても牽引されています。

目次

第1章 市場範囲と調査手法

• 市場の定義
• 目的
• 市場範囲
• セグメンテーション
• 調査手法

第2章 市場概要

• イントロダクション
  • 概要
    • 市場構成とシナリオ
• 市場に影響を与える主な要因
  • 市場促進要因
  • 市場抑制要因

第3章 世界の線維筋痛症治療市場：薬剤クラス別

• 世界の抗けいれん薬市場：地域別
• 世界の抗うつ薬市場：地域別
• 世界の筋弛緩薬市場：地域別
• 世界のその他の市場：地域別

第4章 世界の線維筋痛症治療市場：流通チャネル別

• 世界のドラッグストア・小売薬局市場：地域別
• 世界の病院薬局市場：地域別
• 世界のオンラインプロバイダー市場：地域別

第5章 世界の線維筋痛症治療市場：地域別

• 北米
  • 北米の市場：国別
    • 米国
    • カナダ
    • メキシコ
    • その他北米地域
• 欧州
  • 欧州の市場：国別
    • ドイツ
    • 英国
    • フランス
    • ロシア
    • スペイン
    • イタリア
    • その他欧州地域
• アジア太平洋
  • アジア太平洋の市場：国別
    • 中国
    • 日本
    • インド
    • 韓国
    • シンガポール
    • マレーシア
    • その他アジア太平洋地域
• ラテンアメリカ・中東・アフリカ
  • ラテンアメリカ・中東・アフリカの市場：国別
    • ブラジル
    • アルゼンチン
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • ナイジェリア
    • その他ラテンアメリカ・中東・アフリカ地域

第6章 企業プロファイル

• Abbott Laboratories
• AbbVie, Inc
• Novartis AG
• Eli Lilly And Company
• Amneal Pharmaceuticals, Inc
• Teva Pharmaceutical Industries Ltd
• Zydus Lifesciences Ltd
• Lupin Limited
• Viatris, Inc
• Sun Pharmaceutical Industries Ltd

LIST OF TABLES

• TABLE 1 Global Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 2 Global Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 3 Global Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 4 Global Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 5 Global Anticonvulsants Market by Region, 2019 - 2022, USD Million
• TABLE 6 Global Anticonvulsants Market by Region, 2023 - 2030, USD Million
• TABLE 7 Global Antidepressants Market by Region, 2019 - 2022, USD Million
• TABLE 8 Global Antidepressants Market by Region, 2023 - 2030, USD Million
• TABLE 9 Global Muscle Relaxants Market by Region, 2019 - 2022, USD Million
• TABLE 10 Global Muscle Relaxants Market by Region, 2023 - 2030, USD Million
• TABLE 11 Global Others Market by Region, 2019 - 2022, USD Million
• TABLE 12 Global Others Market by Region, 2023 - 2030, USD Million
• TABLE 13 Global Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 14 Global Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 15 Global Drug stores & Retail Pharmacies Market by Region, 2019 - 2022, USD Million
• TABLE 16 Global Drug stores & Retail Pharmacies Market by Region, 2023 - 2030, USD Million
• TABLE 17 Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Million
• TABLE 18 Global Hospital Pharmacies Market by Region, 2023 - 2030, USD Million
• TABLE 19 Global Online Providers Market by Region, 2019 - 2022, USD Million
• TABLE 20 Global Online Providers Market by Region, 2023 - 2030, USD Million
• TABLE 21 Global Fibromyalgia Treatment Market by Region, 2019 - 2022, USD Million
• TABLE 22 Global Fibromyalgia Treatment Market by Region, 2023 - 2030, USD Million
• TABLE 23 North America Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 24 North America Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 25 North America Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 26 North America Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 27 North America Anticonvulsants Market by Country, 2019 - 2022, USD Million
• TABLE 28 North America Anticonvulsants Market by Country, 2023 - 2030, USD Million
• TABLE 29 North America Antidepressants Market by Country, 2019 - 2022, USD Million
• TABLE 30 North America Antidepressants Market by Country, 2023 - 2030, USD Million
• TABLE 31 North America Muscle Relaxants Market by Country, 2019 - 2022, USD Million
• TABLE 32 North America Muscle Relaxants Market by Country, 2023 - 2030, USD Million
• TABLE 33 North America Others Market by Country, 2019 - 2022, USD Million
• TABLE 34 North America Others Market by Country, 2023 - 2030, USD Million
• TABLE 35 North America Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 36 North America Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 37 North America Drug stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 38 North America Drug stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
• TABLE 39 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 40 North America Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
• TABLE 41 North America Online Providers Market by Country, 2019 - 2022, USD Million
• TABLE 42 North America Online Providers Market by Country, 2023 - 2030, USD Million
• TABLE 43 North America Fibromyalgia Treatment Market by Country, 2019 - 2022, USD Million
• TABLE 44 North America Fibromyalgia Treatment Market by Country, 2023 - 2030, USD Million
• TABLE 45 US Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 46 US Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 47 US Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 48 US Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 49 US Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 50 US Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 51 Canada Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 52 Canada Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 53 Canada Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 54 Canada Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 55 Canada Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 56 Canada Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 57 Mexico Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 58 Mexico Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 59 Mexico Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 60 Mexico Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 61 Mexico Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 62 Mexico Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 63 Rest of North America Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 64 Rest of North America Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 65 Rest of North America Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 66 Rest of North America Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 67 Rest of North America Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 68 Rest of North America Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 69 Europe Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 70 Europe Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 71 Europe Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 72 Europe Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 73 Europe Anticonvulsants Market by Country, 2019 - 2022, USD Million
• TABLE 74 Europe Anticonvulsants Market by Country, 2023 - 2030, USD Million
• TABLE 75 Europe Antidepressants Market by Country, 2019 - 2022, USD Million
• TABLE 76 Europe Antidepressants Market by Country, 2023 - 2030, USD Million
• TABLE 77 Europe Muscle Relaxants Market by Country, 2019 - 2022, USD Million
• TABLE 78 Europe Muscle Relaxants Market by Country, 2023 - 2030, USD Million
• TABLE 79 Europe Others Market by Country, 2019 - 2022, USD Million
• TABLE 80 Europe Others Market by Country, 2023 - 2030, USD Million
• TABLE 81 Europe Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 82 Europe Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 83 Europe Drug stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 84 Europe Drug stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
• TABLE 85 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 86 Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
• TABLE 87 Europe Online Providers Market by Country, 2019 - 2022, USD Million
• TABLE 88 Europe Online Providers Market by Country, 2023 - 2030, USD Million
• TABLE 89 Europe Fibromyalgia Treatment Market by Country, 2019 - 2022, USD Million
• TABLE 90 Europe Fibromyalgia Treatment Market by Country, 2023 - 2030, USD Million
• TABLE 91 Germany Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 92 Germany Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 93 Germany Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 94 Germany Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 95 Germany Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 96 Germany Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 97 UK Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 98 UK Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 99 UK Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 100 UK Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 101 UK Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 102 UK Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 103 France Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 104 France Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 105 France Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 106 France Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 107 France Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 108 France Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 109 Russia Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 110 Russia Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 111 Russia Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 112 Russia Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 113 Russia Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 114 Russia Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 115 Spain Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 116 Spain Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 117 Spain Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 118 Spain Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 119 Spain Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 120 Spain Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 121 Italy Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 122 Italy Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 123 Italy Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 124 Italy Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 125 Italy Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 126 Italy Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 127 Rest of Europe Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 128 Rest of Europe Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 129 Rest of Europe Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 130 Rest of Europe Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 131 Rest of Europe Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 132 Rest of Europe Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 133 Asia Pacific Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 134 Asia Pacific Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 135 Asia Pacific Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 136 Asia Pacific Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 137 Asia Pacific Anticonvulsants Market by Country, 2019 - 2022, USD Million
• TABLE 138 Asia Pacific Anticonvulsants Market by Country, 2023 - 2030, USD Million
• TABLE 139 Asia Pacific Antidepressants Market by Country, 2019 - 2022, USD Million
• TABLE 140 Asia Pacific Antidepressants Market by Country, 2023 - 2030, USD Million
• TABLE 141 Asia Pacific Muscle Relaxants Market by Country, 2019 - 2022, USD Million
• TABLE 142 Asia Pacific Muscle Relaxants Market by Country, 2023 - 2030, USD Million
• TABLE 143 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
• TABLE 144 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
• TABLE 145 Asia Pacific Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 146 Asia Pacific Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 147 Asia Pacific Drug stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 148 Asia Pacific Drug stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
• TABLE 149 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 150 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
• TABLE 151 Asia Pacific Online Providers Market by Country, 2019 - 2022, USD Million
• TABLE 152 Asia Pacific Online Providers Market by Country, 2023 - 2030, USD Million
• TABLE 153 Asia Pacific Fibromyalgia Treatment Market by Country, 2019 - 2022, USD Million
• TABLE 154 Asia Pacific Fibromyalgia Treatment Market by Country, 2023 - 2030, USD Million
• TABLE 155 China Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 156 China Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 157 China Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 158 China Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 159 China Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 160 China Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 161 Japan Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 162 Japan Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 163 Japan Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 164 Japan Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 165 Japan Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 166 Japan Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 167 India Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 168 India Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 169 India Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 170 India Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 171 India Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 172 India Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 173 South Korea Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 174 South Korea Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 175 South Korea Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 176 South Korea Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 177 South Korea Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 178 South Korea Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 179 Singapore Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 180 Singapore Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 181 Singapore Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 182 Singapore Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 183 Singapore Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 184 Singapore Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 185 Malaysia Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 186 Malaysia Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 187 Malaysia Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 188 Malaysia Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 189 Malaysia Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 190 Malaysia Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 191 Rest of Asia Pacific Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 192 Rest of Asia Pacific Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 193 Rest of Asia Pacific Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 194 Rest of Asia Pacific Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 195 Rest of Asia Pacific Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 196 Rest of Asia Pacific Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 197 LAMEA Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 198 LAMEA Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 199 LAMEA Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 200 LAMEA Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 201 LAMEA Anticonvulsants Market by Country, 2019 - 2022, USD Million
• TABLE 202 LAMEA Anticonvulsants Market by Country, 2023 - 2030, USD Million
• TABLE 203 LAMEA Antidepressants Market by Country, 2019 - 2022, USD Million
• TABLE 204 LAMEA Antidepressants Market by Country, 2023 - 2030, USD Million
• TABLE 205 LAMEA Muscle Relaxants Market by Country, 2019 - 2022, USD Million
• TABLE 206 LAMEA Muscle Relaxants Market by Country, 2023 - 2030, USD Million
• TABLE 207 LAMEA Others Market by Country, 2019 - 2022, USD Million
• TABLE 208 LAMEA Others Market by Country, 2023 - 2030, USD Million
• TABLE 209 LAMEA Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 210 LAMEA Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 211 LAMEA Drug stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 212 LAMEA Drug stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
• TABLE 213 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 214 LAMEA Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
• TABLE 215 LAMEA Online Providers Market by Country, 2019 - 2022, USD Million
• TABLE 216 LAMEA Online Providers Market by Country, 2023 - 2030, USD Million
• TABLE 217 LAMEA Fibromyalgia Treatment Market by Country, 2019 - 2022, USD Million
• TABLE 218 LAMEA Fibromyalgia Treatment Market by Country, 2023 - 2030, USD Million
• TABLE 219 Brazil Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 220 Brazil Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 221 Brazil Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 222 Brazil Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 223 Brazil Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 224 Brazil Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 225 Argentina Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 226 Argentina Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 227 Argentina Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 228 Argentina Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 229 Argentina Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 230 Argentina Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 231 UAE Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 232 UAE Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 233 UAE Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 234 UAE Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 235 UAE Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 236 UAE Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 237 Saudi Arabia Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 238 Saudi Arabia Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 239 Saudi Arabia Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 240 Saudi Arabia Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 241 Saudi Arabia Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 242 Saudi Arabia Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 243 South Africa Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 244 South Africa Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 245 South Africa Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 246 South Africa Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 247 South Africa Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 248 South Africa Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 249 Nigeria Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 250 Nigeria Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 251 Nigeria Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 252 Nigeria Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 253 Nigeria Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 254 Nigeria Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 255 Rest of LAMEA Fibromyalgia Treatment Market, 2019 - 2022, USD Million
• TABLE 256 Rest of LAMEA Fibromyalgia Treatment Market, 2023 - 2030, USD Million
• TABLE 257 Rest of LAMEA Fibromyalgia Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 258 Rest of LAMEA Fibromyalgia Treatment Market by Drug Class, 2023 - 2030, USD Million
• TABLE 259 Rest of LAMEA Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 260 Rest of LAMEA Fibromyalgia Treatment Market by Distribution Channel, 2023 - 2030, USD Million
• TABLE 261 Key Information - Abbott Laboratories
• TABLE 262 Key information - AbbVie, Inc.
• TABLE 263 Key Information - Novartis AG
• TABLE 264 Key Information - Eli Lilly And Company
• TABLE 265 Key Information - Amneal Pharmaceuticals, INc.
• TABLE 266 Key Information - Teva Pharmaceuticals Industries Ltd.
• TABLE 267 Key Information - Zydus Lifesciences Ltd.
• TABLE 268 Key Information - Lupin Limited
• TABLE 269 key information - Viatris, Inc.
• TABLE 270 Key Information - Sun Pharmaceutical Industries Ltd.

List of Figures

• FIG 1 Methodology for the research
• FIG 2 Global Fibromyalgia Treatment Market share by Drug Class, 2022
• FIG 3 Global Fibromyalgia Treatment Market share by Drug Class, 2030
• FIG 4 Global Fibromyalgia Treatment Market by Drug Class, 2019 - 2030, USD Million
• FIG 5 Global Fibromyalgia Treatment Market share by Distribution Channel, 2022
• FIG 6 Global Fibromyalgia Treatment Market share by Distribution Channel, 2030
• FIG 7 Global Fibromyalgia Treatment Market by Distribution Channel, 2019 - 2030, USD Million
• FIG 8 Global Fibromyalgia Treatment Market share by Region, 2022
• FIG 9 Global Fibromyalgia Treatment Market share by Region, 2030
• FIG 10 Global Fibromyalgia Treatment Market by Region, 2019 - 2030, USD Million
• FIG 11 Swot analysis: Abbott laboratories

The Global Fibromyalgia Treatment Market size is expected to reach $4 billion by 2030, rising at a market growth of 4.4% CAGR during the forecast period.

Muscle Relaxants are widely utilized by people to ease muscle stiffness or spasms and help in relaxing painful knots. As road accidents are increasing, the usage of muscle relaxant is increasing. Therefore, Muscle relaxants accounted for $202.3 million revenue in 2022. Road traffic accidents kill approximately 1.3 million people annually and injure between 20 and 50 million others, as stated by the WHO report. Over fifty percent of road traffic deaths and injuries involve vulnerable road users, such as pedestrians, motorcyclists, cyclists, and passengers. Children and young adults aged 5 to 29 are disproportionately susceptible to road traffic injuries.

Among people of this age, it is the most common cause of death. Males under 25 are more likely than females to be involved in traffic incidents. According to statistics, males account for 73% of the traffic fatalities in this age group. 93% of road traffic fatalities occur in low- and middle-income countries, increasing road traffic injury rates in developing nations. Consequently, the rise in road accidents due to various factors is anticipated to increase the cases of fibromyalgia, which will raise the need for fibromyalgia treatment, thereby driving market expansion. Some of the factors impacting the market are research for novel drugs and possible uses of combination therapy, Co-relation between lupus and fibromyalgia, and non-drug alternative.

Chronic fibromyalgia substantially limits patients' ability to engage in typical social and professional activities and makes maintaining relationships with friends, family, and coworkers difficult. The full spectrum of pain, tiredness, sleep disturbances, and depression symptoms cannot be fully addressed by any available medicines. The growing need for better and more effective treatment options for FM will spur pharmaceutical companies to continue their research and development efforts, driving the market. Lupus is a common (chronic) autoimmune disorder that can be debilitating and has the potential to affect a variety of body systems. Lupus is developed when the immune system, which typically aids in defending the body against infection and disease, targets its tissues. As a result, it is anticipated that their prevalence will rise along with the number of lupus cases, fueling demand for fibromyalgia treatment options and fueling market expansion.

However, Fibromyalgia can be managed with non-drug alternatives with many benefits while incurring no side effects. One such alternative is stress management. This works by creating a strategy to prevent or reduce overexertion and emotional tension and allowing oneself daily relaxation time. This is expected to hamper the market growth in the projected period. Fibromyalgia is reportedly widespread among those who have recovered from COVID-19, according to a study from the National Center for Biotechnology Information (NCBI). This data suggests that fibromyalgia may be more common among those who have had COVID-19, increasing the need for treatment after the pandemic. Hence, the pandemic caused the market to decline, but later, the market started to recover due to the growing number of FM cases.

Drug Class Outlook

Based on drug class, the market is segmented into antidepressants, anticonvulsants, muscle relaxants and others. The antidepressants segment acquired a substantial revenue share in the market in 2022. This is because there are several antidepressant choices accessible for fibromyalgia patients. Multiple antidepressants are readily available, allowing for greater prescribing flexibility and a greater chance that each patient will receive the right treatment. This market's expansion is also anticipated to be aided by the availability of generic versions of antidepressants approved for use in fibromyalgia patients.

Distribution Channel Outlook

On the basis of distribution channel, the market is divided into hospital pharmacies, drug stores & retail pharmacies and online providers. The drug stores & retail pharmacies segment witnessed the largest revenue share in the market in 2022. The segment growth is due to the presence of drug stores and retail pharmacies in multiple locations in diverse neighborhoods and communities, which are extensively accessible to the general public. This ubiquitous presence guarantees easy access to drugs and treatments for those with fibromyalgia.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region registered the highest revenue share in the market in 2022. This is due to several variables, including increased fibromyalgia prevalence, new treatment choices, and supporting healthcare infrastructure. A vital healthcare infrastructure, high purchasing power, and increased acceptance of fibromyalgia drugs are anticipated to fuel market expansion. The market in this region is also driven by numerous significant players and developments in manufacturing technology these businesses use to manufacture effective goods.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Novartis AG, Eli Lilly And Company, Amneal Pharmaceuticals, Inc., Teva Pharmaceuticals Industries Ltd., Zydus Lifesciences Ltd., Lupin Limited, Abbott Laboratories, Viatris, Inc., and Sun Pharmaceutical Industries Ltd.

Scope of the Study

Market Segments covered in the Report:

By Drug Class

• Anticonvulsants
• Antidepressants
• Muscle Relaxants
• Others

By Distribution Channel

• Drug stores & Retail Pharmacies
• Hospital Pharmacies
• Online Providers

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• AbbVie, Inc.
• Novartis AG
• Eli Lilly And Company
• Amneal Pharmaceuticals, Inc.
• Teva Pharmaceuticals Industries Ltd.
• Zydus Lifesciences Ltd.
• Lupin Limited
• Abbott Laboratories
• Viatris, Inc.
• Sun Pharmaceutical Industries Ltd.

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Fibromyalgia Treatment Market, by Drug Class
  • 1.4.2 Global Fibromyalgia Treatment Market, by Distribution Channel
  • 1.4.3 Global Fibromyalgia Treatment Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market Overview

• 2.1 Introduction
  • 2.1.1 Overview
    • 2.1.1.1 Market composition & scenario
• 2.2 Key Factors Impacting the Market
  • 2.2.1 Market Drivers
  • 2.2.2 Market Restraints

Chapter 3. Global Fibromyalgia Treatment Market by Drug Class

• 3.1 Global Anticonvulsants Market by Region
• 3.2 Global Antidepressants Market by Region
• 3.3 Global Muscle Relaxants Market by Region
• 3.4 Global Others Market by Region

Chapter 4. Global Fibromyalgia Treatment Market by Distribution Channel

• 4.1 Global Drug stores & Retail Pharmacies Market by Region
• 4.2 Global Hospital Pharmacies Market by Region
• 4.3 Global Online Providers Market by Region

Chapter 5. Global Fibromyalgia Treatment Market by Region

• 5.1 North America Fibromyalgia Treatment Market
  • 5.1.1 North America Fibromyalgia Treatment Market by Drug Class
    • 5.1.1.1 North America Anticonvulsants Market by Country
    • 5.1.1.2 North America Antidepressants Market by Country
    • 5.1.1.3 North America Muscle Relaxants Market by Country
    • 5.1.1.4 North America Others Market by Country
  • 5.1.2 North America Fibromyalgia Treatment Market by Distribution Channel
    • 5.1.2.1 North America Drug stores & Retail Pharmacies Market by Country
    • 5.1.2.2 North America Hospital Pharmacies Market by Country
    • 5.1.2.3 North America Online Providers Market by Country
  • 5.1.3 North America Fibromyalgia Treatment Market by Country
    • 5.1.3.1 US Fibromyalgia Treatment Market
      • 5.1.3.1.1 US Fibromyalgia Treatment Market by Drug Class
      • 5.1.3.1.2 US Fibromyalgia Treatment Market by Distribution Channel
    • 5.1.3.2 Canada Fibromyalgia Treatment Market
      • 5.1.3.2.1 Canada Fibromyalgia Treatment Market by Drug Class
      • 5.1.3.2.2 Canada Fibromyalgia Treatment Market by Distribution Channel
    • 5.1.3.3 Mexico Fibromyalgia Treatment Market
      • 5.1.3.3.1 Mexico Fibromyalgia Treatment Market by Drug Class
      • 5.1.3.3.2 Mexico Fibromyalgia Treatment Market by Distribution Channel
    • 5.1.3.4 Rest of North America Fibromyalgia Treatment Market
      • 5.1.3.4.1 Rest of North America Fibromyalgia Treatment Market by Drug Class
      • 5.1.3.4.2 Rest of North America Fibromyalgia Treatment Market by Distribution Channel
• 5.2 Europe Fibromyalgia Treatment Market
  • 5.2.1 Europe Fibromyalgia Treatment Market by Drug Class
    • 5.2.1.1 Europe Anticonvulsants Market by Country
    • 5.2.1.2 Europe Antidepressants Market by Country
    • 5.2.1.3 Europe Muscle Relaxants Market by Country
    • 5.2.1.4 Europe Others Market by Country
  • 5.2.2 Europe Fibromyalgia Treatment Market by Distribution Channel
    • 5.2.2.1 Europe Drug stores & Retail Pharmacies Market by Country
    • 5.2.2.2 Europe Hospital Pharmacies Market by Country
    • 5.2.2.3 Europe Online Providers Market by Country
  • 5.2.3 Europe Fibromyalgia Treatment Market by Country
    • 5.2.3.1 Germany Fibromyalgia Treatment Market
      • 5.2.3.1.1 Germany Fibromyalgia Treatment Market by Drug Class
      • 5.2.3.1.2 Germany Fibromyalgia Treatment Market by Distribution Channel
    • 5.2.3.2 UK Fibromyalgia Treatment Market
      • 5.2.3.2.1 UK Fibromyalgia Treatment Market by Drug Class
      • 5.2.3.2.2 UK Fibromyalgia Treatment Market by Distribution Channel
    • 5.2.3.3 France Fibromyalgia Treatment Market
      • 5.2.3.3.1 France Fibromyalgia Treatment Market by Drug Class
      • 5.2.3.3.2 France Fibromyalgia Treatment Market by Distribution Channel
    • 5.2.3.4 Russia Fibromyalgia Treatment Market
      • 5.2.3.4.1 Russia Fibromyalgia Treatment Market by Drug Class
      • 5.2.3.4.2 Russia Fibromyalgia Treatment Market by Distribution Channel
    • 5.2.3.5 Spain Fibromyalgia Treatment Market
      • 5.2.3.5.1 Spain Fibromyalgia Treatment Market by Drug Class
      • 5.2.3.5.2 Spain Fibromyalgia Treatment Market by Distribution Channel
    • 5.2.3.6 Italy Fibromyalgia Treatment Market
      • 5.2.3.6.1 Italy Fibromyalgia Treatment Market by Drug Class
      • 5.2.3.6.2 Italy Fibromyalgia Treatment Market by Distribution Channel
    • 5.2.3.7 Rest of Europe Fibromyalgia Treatment Market
      • 5.2.3.7.1 Rest of Europe Fibromyalgia Treatment Market by Drug Class
      • 5.2.3.7.2 Rest of Europe Fibromyalgia Treatment Market by Distribution Channel
• 5.3 Asia Pacific Fibromyalgia Treatment Market
  • 5.3.1 Asia Pacific Fibromyalgia Treatment Market by Drug Class
    • 5.3.1.1 Asia Pacific Anticonvulsants Market by Country
    • 5.3.1.2 Asia Pacific Antidepressants Market by Country
    • 5.3.1.3 Asia Pacific Muscle Relaxants Market by Country
    • 5.3.1.4 Asia Pacific Others Market by Country
  • 5.3.2 Asia Pacific Fibromyalgia Treatment Market by Distribution Channel
    • 5.3.2.1 Asia Pacific Drug stores & Retail Pharmacies Market by Country
    • 5.3.2.2 Asia Pacific Hospital Pharmacies Market by Country
    • 5.3.2.3 Asia Pacific Online Providers Market by Country
  • 5.3.3 Asia Pacific Fibromyalgia Treatment Market by Country
    • 5.3.3.1 China Fibromyalgia Treatment Market
      • 5.3.3.1.1 China Fibromyalgia Treatment Market by Drug Class
      • 5.3.3.1.2 China Fibromyalgia Treatment Market by Distribution Channel
    • 5.3.3.2 Japan Fibromyalgia Treatment Market
      • 5.3.3.2.1 Japan Fibromyalgia Treatment Market by Drug Class
      • 5.3.3.2.2 Japan Fibromyalgia Treatment Market by Distribution Channel
    • 5.3.3.3 India Fibromyalgia Treatment Market
      • 5.3.3.3.1 India Fibromyalgia Treatment Market by Drug Class
      • 5.3.3.3.2 India Fibromyalgia Treatment Market by Distribution Channel
    • 5.3.3.4 South Korea Fibromyalgia Treatment Market
      • 5.3.3.4.1 South Korea Fibromyalgia Treatment Market by Drug Class
      • 5.3.3.4.2 South Korea Fibromyalgia Treatment Market by Distribution Channel
    • 5.3.3.5 Singapore Fibromyalgia Treatment Market
      • 5.3.3.5.1 Singapore Fibromyalgia Treatment Market by Drug Class
      • 5.3.3.5.2 Singapore Fibromyalgia Treatment Market by Distribution Channel
    • 5.3.3.6 Malaysia Fibromyalgia Treatment Market
      • 5.3.3.6.1 Malaysia Fibromyalgia Treatment Market by Drug Class
      • 5.3.3.6.2 Malaysia Fibromyalgia Treatment Market by Distribution Channel
    • 5.3.3.7 Rest of Asia Pacific Fibromyalgia Treatment Market
      • 5.3.3.7.1 Rest of Asia Pacific Fibromyalgia Treatment Market by Drug Class
      • 5.3.3.7.2 Rest of Asia Pacific Fibromyalgia Treatment Market by Distribution Channel
• 5.4 LAMEA Fibromyalgia Treatment Market
  • 5.4.1 LAMEA Fibromyalgia Treatment Market by Drug Class
    • 5.4.1.1 LAMEA Anticonvulsants Market by Country
    • 5.4.1.2 LAMEA Antidepressants Market by Country
    • 5.4.1.3 LAMEA Muscle Relaxants Market by Country
    • 5.4.1.4 LAMEA Others Market by Country
  • 5.4.2 LAMEA Fibromyalgia Treatment Market by Distribution Channel
    • 5.4.2.1 LAMEA Drug stores & Retail Pharmacies Market by Country
    • 5.4.2.2 LAMEA Hospital Pharmacies Market by Country
    • 5.4.2.3 LAMEA Online Providers Market by Country
  • 5.4.3 LAMEA Fibromyalgia Treatment Market by Country
    • 5.4.3.1 Brazil Fibromyalgia Treatment Market
      • 5.4.3.1.1 Brazil Fibromyalgia Treatment Market by Drug Class
      • 5.4.3.1.2 Brazil Fibromyalgia Treatment Market by Distribution Channel
    • 5.4.3.2 Argentina Fibromyalgia Treatment Market
      • 5.4.3.2.1 Argentina Fibromyalgia Treatment Market by Drug Class
      • 5.4.3.2.2 Argentina Fibromyalgia Treatment Market by Distribution Channel
    • 5.4.3.3 UAE Fibromyalgia Treatment Market
      • 5.4.3.3.1 UAE Fibromyalgia Treatment Market by Drug Class
      • 5.4.3.3.2 UAE Fibromyalgia Treatment Market by Distribution Channel
    • 5.4.3.4 Saudi Arabia Fibromyalgia Treatment Market
      • 5.4.3.4.1 Saudi Arabia Fibromyalgia Treatment Market by Drug Class
      • 5.4.3.4.2 Saudi Arabia Fibromyalgia Treatment Market by Distribution Channel
    • 5.4.3.5 South Africa Fibromyalgia Treatment Market
      • 5.4.3.5.1 South Africa Fibromyalgia Treatment Market by Drug Class
      • 5.4.3.5.2 South Africa Fibromyalgia Treatment Market by Distribution Channel
    • 5.4.3.6 Nigeria Fibromyalgia Treatment Market
      • 5.4.3.6.1 Nigeria Fibromyalgia Treatment Market by Drug Class
      • 5.4.3.6.2 Nigeria Fibromyalgia Treatment Market by Distribution Channel
    • 5.4.3.7 Rest of LAMEA Fibromyalgia Treatment Market
      • 5.4.3.7.1 Rest of LAMEA Fibromyalgia Treatment Market by Drug Class
      • 5.4.3.7.2 Rest of LAMEA Fibromyalgia Treatment Market by Distribution Channel

Chapter 6. Company Profiles

• 6.1 Abbott Laboratories
  • 6.1.1 Company Overview
  • 6.1.2 Financial Analysis
  • 6.1.3 Segmental and Regional Analysis
  • 6.1.4 Research & Development Expense
  • 6.1.5 SWOT Analysis
• 6.2 AbbVie, Inc.
  • 6.2.1 Company Overview
  • 6.2.2 Financial Analysis
  • 6.2.3 Regional Analysis
  • 6.2.4 Research & Development Expense
  • 6.2.5 Recent strategies and developments:
    • 6.2.5.1 Acquisition and Mergers:
• 6.3 Novartis AG
  • 6.3.1 Company Overview
  • 6.3.2 Financial Analysis
  • 6.3.3 Segmental and Regional Analysis
  • 6.3.4 Research & Development Expense
  • 6.3.5 Recent strategies and developments:
    • 6.3.5.1 Acquisition and Mergers:
• 6.4 Eli Lilly And Company
  • 6.4.1 Company Overview
  • 6.4.2 Financial Analysis
  • 6.4.3 Regional Analysis
  • 6.4.4 Research & Development Expenses
• 6.5 Amneal Pharmaceuticals, Inc.
  • 6.5.1 Company Overview
  • 6.5.2 Financial Analysis
  • 6.5.3 Segmental Analysis
  • 6.5.4 Research & Development Expenses
• 6.6 Teva Pharmaceutical Industries Ltd.
  • 6.6.1 Company Overview
  • 6.6.2 Financial Analysis
  • 6.6.3 Regional Analysis
  • 6.6.4 Research & Development Expenses
• 6.7 Zydus Lifesciences Ltd.
  • 6.7.1 Company Overview
  • 6.7.2 Financial Analysis
  • 6.7.3 Segmental and Regional Analysis
  • 6.7.4 Research & Development Expense
  • 6.7.5 Recent strategies and developments:
    • 6.7.5.1 Trials and Approvals:
• 6.8 Lupin Limited
  • 6.8.1 Company Overview
  • 6.8.2 Financial Analysis
  • 6.8.3 Recent strategies and developments:
    • 6.8.3.1 Trials and Approvals:
• 6.9 Viatris, Inc.
  • 6.9.1 Company Overview
  • 6.9.2 Financial Analysis
  • 6.9.3 Segmental Analysis
  • 6.9.4 Research & Development Expense
• 6.10. Sun Pharmaceutical Industries Ltd.
  • 6.10.1 Company Overview
  • 6.10.2 Financial Analysis
  • 6.10.3 Regional Analysis
  • 6.10.4 Research & Development Expenses